SCYNEXIS INC Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by SCYNEXIS, Inc. on August 3, 2020, regarding a corporate event related to its Nasdaq listing status. The company is incorporated in Delaware and trades under the symbol SCYX on the Nasdaq Global Market.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance regarding stock listing requirements.
Material Changes
The primary material event reported is the resolution of a Nasdaq listing deficiency:
- Deficiency: On April 21, 2020, Nasdaq notified the company that its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.
- Action Taken: On July 16, 2020, the company implemented a 1-for-10 reverse stock split, effective July 17, 2020.
- Resolution: On August 3, 2020, Nasdaq confirmed that the closing bid price had been at or above $1.00 for the 10 consecutive business days following the split (July 17 to July 31, 2020).
- Outcome: The company has regained compliance with Listing Rule 5450(a)(1), and the matter is closed.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of new risks or contingencies beyond the resolved listing issue.
Key Facts for Investor Verification
- Confirm the current trading price of SCYX to ensure continued compliance with the $1.00 minimum bid requirement.
- Verify the post-split share count and capitalization structure following the 1-for-10 reverse stock split.
- Review subsequent filings for any new Nasdaq deficiency notices or financial updates not covered in this 8-K.